QURE Healthcare
生物技术研究
San Francsico,CA 1,352 位关注者
A platform to assess clinical decision-making and the utility of emerging medical technologies
关于我们
QURE Healthcare’s proprietary platform is a scientifically-validated engagement tool that rapidly measures personalized healthcare decisions, by improving real-world practice and evaluating emerging health technologies (pharma, biotech, diagnostics, digital health). QURE’s results-driven team of experts proudly serves health systems, payers, and life sciences companies to improve evidence-based care delivery. For health systems, physician groups, ACOs, and health plans, our approach drives higher quality, cost-effective clinical decision-making. For life sciences companies, use of our platform, conducted clinical studies, and advisory rapidly and accurately evaluate the real-world use and implications of novel medical products in healthcare systems.
- 网站
-
https://www.QUREhealthcare.com/
QURE Healthcare的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- San Francsico,CA
- 类型
- 私人持股
- 创立
- 2012
- 领域
- Care Variation、Clinical Utility、Value Based Care、Quality Improvement、Advanced Primary Care、Accountable Care Organizations、Precision Medicine、Molecular Diagnostics、Diagnostic Market Access、Test Adoption、Reducing Low Value Care、Reducing Healthcare Costs、Diagnostic Commercialization、Medical Practice、Measuring Physician Decision Making、Health Outcomes、Coverage and Reimbursement、biotech、diagnostics、digital health、precision health、precision medicine、healthtech、emerging technologies、personalized medicine、payer strategy、SaaS、Platform management、go-to-market、commercialization、management consulting、market access、contract negotiation和health system integration
地点
-
主要
US,CA,San Francsico,94133
QURE Healthcare员工
-
Trever Burgon, PhD
-
David Paculdo
Visionary Storyteller | Data Science | Project Management | Product Management
-
Michael van Duren, MD, MBA
Physician Executive | Curious and Innovative Thought Leader | Expert in Reducing Unwarranted Clinical Variation | Value Based Health Care |…
-
Enrico de Belen
Deputy Chief Medical Officer at QURE Healthcare
动态
-
Engage your PCPs with fun, short, evidence-based patient simulations aligned with your highest priority clinical topics. Earn CME and make a proven impact on real-world quality and value. Discover more at www.qurehealthcare.com.
-
-
Are you looking to improve PCP referrals for palliative and hospice care? QURE's case-based measurement and feedback led to a 16% increase in appropriate hospice referrals for a group in the Midwest. Explore more at https://lnkd.in/eJ3q2HGh.
-
-
Help your primary care providers make better evidence-based decisions to improve clinical and financial results. Select modules most important to your organization, from heart failure GDMT?to polypharmacy in dementia. Explore more at https://lnkd.in/eJ3q2HGh.
-
-
Check out the latest QURE randomized controlled trial findings, published last week in BMC Medicine! This clinical utility study explores the real-world impact of Aegis Sciences Corporation's novel Chronic Disease Management Test (CDMT) on patient outcomes, particularly in managing polypharmacy, drug-drug interactions, and medication nonadherence. The CDMT enhanced primary care providers' ability to detect medication nonadherence and drug-drug interactions, enabling more informed and clinically rigorous decision-making. https://lnkd.in/eTbFyJgh #ClinicalUtility #CardiometabolicDisease #Polypharmacy #DiseaseProgression
-